SCHEMBL3270180

SCHEMBL3270180

CC(=O)CCCS.[NaH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8499764 0.97
SCHEMBL1171485 0.88
SCHEMBL18383662 0.86 PAOX (0.56)
SCHEMBL15254370 0.86 PAOX (0.56)
SCHEMBL5050515 0.86 PAOX (0.56)
SCHEMBL17037791 0.86
SCHEMBL21779590 0.86 PAOX (0.56)
SCHEMBL17974195 0.78 KDM4E (0.54)
SCHEMBL441981 0.78
SCHEMBL620309 0.77 ALDH1A1 (0.69)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4335509-B1 NOVEL GLUTAMINYL CYCLASE INHIBITORS AND THE USE THEREOF IN TREATMENT OF VARIOUS DISEASES VALENTA INTELLEKT LTD (RU) 2026-03-11 EP disclosed
EP-3632433-B1 NOVEL GLUTAMINYL CYCLASE INHIBITORS AND THE USE THEREOF IN TREATMENT OF VARIOUS DISEASES NEBOLSIN VLADIMIR EVGENIEVICH (RU) 2025-12-24 EP disclosed
US-20240238195-A1 METHODS AND COMPOSITIONS FOR INHIBITING A NOXIOUS INSULT PATEL ONEEL (AU) 2024-07-18 US disclosed
US-20240114893-A1 CORNEAL STORAGE COMPOSITIONS AUROLAB TRUST (IN) 2024-04-11 US disclosed
US-20240116898-A1 NOVEL GLUTAMINYL CYCLASE INHIBITORS AND THE USE THEREOF IN TREATMENT OF VARIOUS DISEASES LTD "VALENTA-INTELLEKT" (RU) 2024-04-11 US disclosed
EP-4335509-A2 NOVEL GLUTAMINYL CYCLASE INHIBITORS AND THE USE THEREOF IN TREATMENT OF VARIOUS DISEASES LTD "VALENTA-INTELLEKT" (RU) 2024-03-13 EP disclosed
US-11845740-B2 Glutaminyl cyclase inhibitors and the use thereof in treatment of various diseases LTD “Valenta-Intellekt” (RU) 2023-12-19 US disclosed
US-20230136075-A1 TREATMENT FOR SEPSIS-INDUCED ORGAN DYSFUNCTION AUSTIN HEALTH (AU) 2023-05-04 US disclosed
WO-2022243930-A1 DISINFECTING AND CLEANING COMPOSITION COMPRISING ELECTROLYZED WATER SWISS NEWATER HOLDING SARL (CH) 2022-11-24 WO disclosed
US-20210212932-A1 METHODS AND COMPOSITIONS FOR INHIBITING A NOXIOUS INSULT PATEL ONEEL (AU) 2021-07-15 US disclosed
WO-2000024358-A2 SYNTHESIS AND USES OF THIOPENTONE ENANTIOMERS THE UNIVERSITY OF SYDNEY (AU) 2000-05-04 WO disclosed
US-4909799-A Methods for preventing thrombosis; and surgical implant having reduced platelet deposition characteristics THULESIUS OLAV (KW) 1990-03-20 US disclosed
EP-0308802-A2 Composition for preventing and treating thrombosis, and hemocompatible surgical implant therefor Thulesius, Olav, Prof. Dr. (KW) 1989-03-29 EP disclosed
US-4784999-A Novel treatment BEECHAM WUELFING GMBH & CO. KG (DE) 1988-11-15 US disclosed
EP-0267676-A2 Use of 1,3-di-n-butyl-7-(2-oxypropyl) xanthine in the treatment of cerebrovascular or cerebral senility associated disorders, peripheral vascular disease and proliferative skin diseases Beecham Wuelfing GmbH &amp; Co KG (DE) 1988-05-18 EP disclosed
EP-0260127-A2 Xanthine derivatives, their preparation and pharmaceutical compositions containing them BEECHAM - WUELFING GmbH &amp; Co. KG (DE) 1988-03-16 EP disclosed
EP-0223811-A1 USE OF NICORANDIL OR PINACIDIL FOR THE TREATMENT OF PERIPHERAL VASCULAR DISEASE BEECHAM GROUP PLC (GB) 1987-06-03 EP disclosed
WO-1986006960-A2 USE OF NICORANDIL OR PINACIDIL FOR THE TREATMENT OF PERIPHERAL VASCULAR DISEASE BEECHAM GROUP P.L.C. (GB) 1986-12-04 WO disclosed
US-4452811-A VASODILATORS FIDIA S.P.A. (IT) 1984-06-05 US disclosed
US-4296039-A REACTING 2-HALORESORCINOLS OR THEIR MONOETHERS WITH BETA-KETO ESTERS FIDIA S.P.A. (IT) 1981-10-20 US disclosed